advanced search

Welcome: Guest

log in

Medicated Skin Care Products

Publication Date October 2008
Publisher Global Industry Analysts
Product Type Report
Pages 344
ISBN Number not applicable
Product Code GIA00950
Buy this product or for assistance call +44 20 7060 7474

Summary

This report analyzes the worldwide markets for Medicated Skin Care Products in Millions of US$. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Latin America. Annual forecasts are provided for each region for the period of 2001 through 2015. A ten-year historic analysis is also provided for these markets with annual market analytics. The report profiles 135 companies including many key and niche players worldwide such as Advanced Research Laboratories, Allergan, Inc., avVaa World Health Care Products, Blistex, Inc., CCA Industries, Inc., Chattem, Inc., Convatec, FNC Medical Corporation, Galderma Pharma SA, Henkel AG & Co. KgaA, Johnson & Johnson, Neutrogena Corp, Novartis AG, Obagi Medical Products, Inc., Procter & Gamble Company, Reckitt Benckiser Plc., Rohto Pharmaceutical, Mentholatum Co., Inc., Stiefel Laboratories, Schering-Plough Corp., Shiseido Co Ltd, Unilever NV, and Wyeth Corp. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Content

  • I. Introduction, Methodology & Product Definitions
    • Study Reliability and Reporting Limitations
    • Disclaimers
    • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
    • Scope of Study
  • II. Executive Summary
    • 1. Industry Overview & Outlook I
      • The Budding Market I
      • Current and Future Analysis I
      • The Winners and Losers I
    • 2. Market Trends I
      • Riding High on Perceived Value I
      • Exotic Ingredients Paint the Beauty Scape Bright I
      • Unleashing the Younger Dimension of Skin Care I
      • Acne and Ageing Drive Sales I
      • Sunny Side up I
      • Skincare Sales Driven by 'Macho' Spending I
      • The US and the UK Skincare Markets - Bubbling with Activity I
      • Skin Care Gets Lighter I
      • Herbal Skincare Booming I
      • Sensitive Skin Formulations Replacing Harsher Products I
    • 3. Product Overview I
      • Introduction I
      • Basic Structure of Skin I
      • Types of Skin I
      • Skin Diseases and their Treatments I
      • Acne I
      • Treatment Options I
      • Causative Factors I
      • Acne Rosacea I
      • Dry Skin I
      • Fungal Infections I
      • Actinic Keratosis I
      • Eczema/Atopic Dermatitis I
      • Psoriasis I
      • Calluses I
      • Friction Blisters I
      • Black Heel and Palm I
      • Tennis Toe I
      • Acne Mechanica I
      • The Crucial Role of Nutrition II-1
      • Nutraceuticals and Skincare II-1
      • Antioxidants II-1
      • Vitamin A II-1
      • B Vitamins II-1
      • Zinc II-1
      • Deficiencies and Skin Disorders II-1
      • Dermatitis II-1
      • Treatment II-1
      • B Vitamins II-1
      • Vitamin A II-1
      • Vitamin C II-1
      • Eczema II-1
      • Treatment II-1
      • Antioxidants II-1
      • Selenium II-1
      • Essential Fatty Acids II-1
      • Psoriasis II-1
      • Treatment II-1
      • Vitamin D Analogs II-1
      • Vitamin A Derivatives II-1
      • Zinc II-1
      • Selenium II-1
      • Essential Fatty Acids II-1
    • 4. Product Launches II-1
      • Procyte Unveils NEOVA II-1
      • Helix BioMedix Introduces P.A.C. Perfect Product Range II-1
      • Wyeth Consumer Healthcare Launches a New ChapStick II-1
      • Bradley Pharmaceuticals Introduces ROSULA CLK II-1
      • China Shenghuo Introduces 12Ways II-1
      • New Dr. Dan's CortiBalm Medicated Balm for Lips II-1
      • Obagi Launches CLENZIderm M.D II-1
      • Aidance Introduces Tetrasil Cream II-1
      • Silab Introduces New Ingredient II-1
      • Galderma Launches MetroGel 1% Rosacea Treatment Kit II-1
      • SkinMedica Introduces Benzoyl Peroxide Cream II-1
      • L'Oreal Introduces Acne Response Daily Adult Acne Regimen II-1
      • Carolina Unveils Medicated Makeup Range II-1
      • VVF Introduces New Skin Care Soap II-1
      • PCA Launches Teen Acne System II-1
      • avVaa World Unveils Private Label Range Products in Human and Pet Skincare II-1
      • Valvital Expands its Product Offerings II-1
      • Medtech Products Launches Dermoplast Poison Ivy Treatment II-1
      • Markwins Beauty Products Introduces Two New Product Lines under Wet n Wild Brand II-1
      • Schering-Plough Introduces COPPERTONE KIDS(R) CONTINUOUS SPRAY Sunscreens II-1
      • Procter & Gamble Introduces New Olay Ribbons Body Wash II-1
      • Elizabeth Arden Launches Prevage, a Skin Treatment II-1
      • ConvaTec Unveils Aloe Vesta Protective Barrier Skin Spray II-1
    • 5. Recent Industry Activity II-1
      • Stiefel Laboratories Acquires Barrier Therapeutics II-1
      • Allergan to Acquire Aczone Gel 5% II-1
      • Barrier Therapeutics Enters into Agreement with Procter & Gamble II-1
      • Skinvisible Inks an Agreement with Embil II-1
      • OmniReliant Acquires Patented Topical Pharmaceutical Product II-1
      • Galderma Announces Acquisition of CollaGenex II-1
      • Stiefel Laboratories Collaborates with Allergan II-1
      • Blackstone Acquires Minority Stake in Stiefel Laboratories II-1
      • Reckitt Benckiser to Divest Hermal Prescription Skincare Business II-1
      • Galderma Receives FDA Clearance for Differin Gel 0.3% II-1
      • Ranbaxy Acquires 13 Brands from Bristol Myers Squibb II-2
      • Barrier Therapeutics Secures Health Canada Approval for Xolegel II-2
      • Barrier Therapeutics Secures Labeling Expansion for Solag II-2
      • avVaa Enters into Vendor Agreement with Home Shopping Group II-2
      • Stiefel Secures FDA Clearance for Olux-E II-2
      • Procter & Gamble Takes over HDS Cosmetics II-2
      • Chattem Acquires Certain OTC and Consumer Brands from J&J II-2
      • Optoderma Launches Optoderma Skin Care Product Range in The Middle East II-2
      • Reckitt Benckiser Completes the Acquisition of Boots Healthcare II-2
      • Johnson & Johnson Acquires Consumer Healthcare Business of Pfizer II-2
      • Leo Pharma and Foamix Establish Joint Venture for Developing Skin Care Products II-2
      • Derma Sciences Inc Enters into Licensing Agreement with Comvita Limited II-2
      • Novartis Acquires OTC Products from Bristol-Myers Squibb II-2
      • AAGM Secures Marketing Rights in North America for its Skin Care Offerings II-2
      • Chattem Sells pHisoderm Skin Care Range to Mentholatum II-2
      • Johnson & Johnson Consumer France S.A.S. Acquires Biapharm SAS II-2
      • Pfizer Divests Majority of OTC Brands in Europe II-2
    • 6. Focus on Select Players II-2
      • Allergan, Inc. (USA) II-2
      • avVaa World Health Care Products (USA) II-2
      • Blistex, Inc. (USA) II-2
      • CCA Industries, Inc. (USA) II-2
      • Chattem, Inc. (USA) II-2
      • Convatec (USA) II-2
      • FNC Medical Corporation (USA) II-2
      • Galderma Pharma SA (Switzerland) II-2
      • Henkel AG & Co. KgaA (Germany) II-2
      • Johnson & Johnson (USA) II-2
      • Neutrogena Corp (USA) II-2
      • Novartis AG (Switzerland) II-2
      • Obagi Medical Products Inc (USA) II-2
      • Procter & Gamble Company (USA) II-2
      • Reckitt Benckiser Plc (UK) II-2
      • Rohto Pharmaceutical (Japan) II-2
      • Mentholatum Co., Inc. (USA) II-2
      • Stiefel Laboratories (USA) II-2
      • Schering-Plough Corp. (US0A) II-2
      • Shiseido Co Ltd (Japan) II-3
      • Unilever NV (The Netherlands) II-3
      • Wyeth Corp (USA) II-3
    • 7. Global Market Perspective II-3
  • III. Market
    • 1. The United States II
      • A. Market Analysis II
        • Outlook II
        • A Ripe Market II
        • Commoditization Dents Sales II
        • Indian Companies Flock the US Market II
        • Skin Care on the Rise II
        • Select Medicated Skin Care Brands II
        • Product Launches III-1
        • Strategic Developments III-1
        • Select Players III-1
      • B. Market Analytics III-2
    • 2. Canada III-2
      • A. Market Analysis III-2
        • Outlook III-2
        • Select Medicated Skin Care Brands III-2
        • Strategic Development III-2
      • B. Market Analytics III-2
    • 3. Japan III-3
      • A. Market Analysis III-3
        • Outlook III-3
        • Select Japanese Medicated Skin Care Brands III-3
        • Select Players III-3
        • Product Launch III-3
      • B. Market Analytics III-3
    • 4. Europe III-3
      • Market Analysis III-3
    • 4a. France III-3
      • A. Market Analysis III-3
        • Outlook III-3
        • Select Medicated Skin Care Brands III-3
        • Product Launches III-3
        • Select Player III-3
      • B. Market Analytics III-3
    • 4b. Germany III-4
      • A. Market Analysis III-4
        • Outlook III-4
        • Select Medicated Skin Care Brands III-4
      • B. Market Analytics III-4
    • 4c. Italy III-4
      • Market Analysis III-4
    • 4d. The United Kingdom III-4
      • A. Market Analysis III-4
        • Outlook III-4
        • Select Medicated Skin Care Brands III-4
        • Reigning Whites for UK's Medicated Skin Care Market III-4
        • Demand for Emollient Products Drives Therapeutic Skin Care Market III-4
        • Select Players III-4
      • B. Market Analytics III-4
    • 4e. Rest of Europe III-5
      • A. Market Analysis III-5
        • Outlook III-5
        • Select Medicated Skin Care Brands III-5
        • Select Medicated Cleansers/Acne Remedies Brands III-5
        • Strategic Developments III-5
        • Select Players III-5
      • B. Market Analytics III-5
    • 5. Asia Pacific III-5
      • A. Market Analysis III-5
        • Outlook III-5
        • Select Medicated Skin Care Brands in Asia-Pacific III-5
        • Select Medicated Cleansers/Acne Remedies Brands in Asia-Pacific III-5
        • Skin Whitening Product Manufacturers in Quest for Newer USPs III-5
        • China III-5
        • Chinese Skincare Market: Growing Leaps and Bounds III-5
        • Product Launch III-5
        • Strategic Development III-5
      • B. Market Analytics III-5
    • 6. Latin America III-6
      • A. Market Analysis III-6
        • Outlook III-6
        • Select Medicated Skin Care Brands in Latin America III-6
      • B. Market Analytics III-6
  • IV. Competitive Landscape
  • List of Tables
    • Table 1: Global Skin Care Market by Regions (2008 & 2010) (includes corresponding Graph/Chart) I
    • Table 2: World Recent past, Current & Future Analysis for Medicated Skin Care Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010. (includes corresponding Graph/Chart) II-3
    • Table 3: World Long-term Projections for Medicated Skin Care Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) II-3
    • Table 4: World Historic Review for Medicated Skin Care Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart) II-3
    • Table 5: World 20-Year Perspective for Medicated Skin Care Products by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin America Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart) II-3
    • Table 6: Leading Categories in the US Skin Care Market (2006 & 2007): Percentage Breakdown by Value Sales for Facial Antiaging, Facial Cleansers, Facial Moisturizers, Acne Treatments, Depilatories, Fade/bleach, and Body Antiaging (includes corresponding Graph/Chart) II
    • Table 7: Leading Categories in the US Skin Care Market (2006 & 2007): Percentage Breakdown by Volume Sales for Facial Cleansers, Acne Treatments, Facial Antiaging, Facial Moisturizers, Depilatories, Fade/bleach, and Body Antiaging (includes corresponding Graph/Chart) II
    • Table 8: Leading Players in the US Acne Treatment Market (Recent past Data for 2004): Percentage Breakdown for Neutrogena, Johnson & Johnson, Boots Healthcare, GlaxoSmithKline, Blistex, Noxell, Nature's Cure, Alberto-Culver, Andrew Jergens, Private Label and Others (includes corresponding Graph/Chart) II
    • Table 9: Leading Brands in US Acne Treatment Market (2006 & 2007): Percentage Market Share by Value Sales in Drug Stores for University Medical Acnefree, Neutrogena Oil Free Acne Wash, Clearasil Ultra, Clearasil, Oxy, Aveeno Clear Complexion, Johnson's Cin & Clr Advantage, Biore Pore Perfect, Neutrogena Rapid Clear, Neutrogena Acne Stress Control, and Others (includes corresponding Graph/Chart) II
    • Table 10: Leading Brands in US Acne Treatment Market (2006 & 2007): Percentage Market Share by Volume Sales in Drug Stores for Neutrogena Oil Free Acne Wash, Clearasil Ultra, Clearasil, Oxy, Johnson's Clean & Clear, Johnson's Cln & Clr Advantage, University Medical Acnefree, Aveeno Clear Complexion, Biore Pore Perfect, Neutrogena Rapid Clear, and Others (includes corresponding Graph/Chart) II
    • Table 11: Leading Brands in US Acne Treatment Market (Recent past Data for 2005): Percentage Market Share by Value Sales for Clearasil, Neutrogena Oil Free, Johnson's Clean & Clear, Oxy, Stridex, Biore Pore Perfect, Aveeno Clear Complexion, Johnson's Clean & Clear Advantage, Neutrogena Clear Pore, Johnson's Clean & Clear Blackhead Cleanser and Others (includes corresponding Graph/Chart) II
    • Table 12: Leading Brands in US Acne Treatment Market (Recent past Data for 2005): Percentage Market Share by Volume Sales for Clearasil, Neutrogena Oil Free, Johnson's Clean & Clear, Oxy, Stridex, Johnson's clean & Clear Blackhead Cleanser, Biore Pore Perfect, Johnson's Clean & Clear Advantage, Neutrogena Clear Pore, Aveeno Clear Complexion and Others (includes corresponding Graph/Chart) II
    • Table 13: Leading Distribution Channels in US Acne Treatment Market (Recent past Data for 2004): Market Share by Value Sales for Mass outlets, Food outlets and Drug outlets (includes corresponding Graph/Chart) II
    • Table 14: Leading Brands in US First Aid Ointments/ Antiseptics Market (Recent past Data for 2005): Percentage Market Share by Value Sales for Neosporin plus, Neosporin, Mederma, Aquaphor, Polysporin, Solarcaine, Bactine, Neosporin Scar Solution, Private Label and Others (includes corresponding Graph/Chart) II
    • Table 15: Leading Brands in US First Aid Ointments/ Antiseptics Market (Recent past Data for 2005): Percentage Market Share by Volume Sales for Neosporin plus, Neosporin, BD, Aquaphor, Bactine, Polysporin, Solarcaine, Mederma, Betadine, Neosporin Scar Solution, Private Label and Others (includes corresponding Graph/Chart) II
    • Table 16: Leading Distribution Channels in US Lip Balms/Cold Sore Medications Market (2006 & 2007): Market Share by Value Sales for Mass Outlets, Drug Stores and Supermarkets (includes corresponding Graph/Chart) II
    • Table 17: Leading Distribution Channels in US Lip Balms/Cold Sore Medications Market (2006 & 2007): Market Share by Volume Sales for Mass Outlets, Drug Stores and Supermarkets (includes corresponding Graph/Chart) II
    • Table 18: Leading Brands in US Lip Balm/Cold Sore Medications Market (2007): Percentage Market Share by Value Sales for Abreva, Chapstick, Burt's Bees, Burt's Bees Lip Shimmer, Carmex, Blistex, Chapstick Lip Moisturizer, Releev, Campho Phenique, Blistex Lip Infusion, Private Label, and Others (includes corresponding Graph/Chart) III-1
    • Table 19: Leading Brands in US Lip Balm/Cold Sore Medications Market (2007): Percentage Market Share by Volume Sales for Chapstick, Carmex, Blistex, Burt's Bees, Burt's Bees Lip Shimmer, Chapstick Lip Moisturizer, Abreva, Blistex Lip Infusion, Campho Phenique, Releev, Private Label, and Others (includes corresponding Graph/Chart) III-1
    • Table 20: Leading Brands in US First AID (Anti-Itch Treatment) Market (Recent past Data for 2005): Percentage Market Share by Value Sales for Benadryl, Cortizone 10, Cortaid, Aveeno, Cortizone 10 plus, Lotrimin AF, Lamisil AT, Lanacane, Gold Bond, Zanfel, Private Label and Others (includes corresponding Graph/Chart) III-1
    • Table 21: Leading Brands in US First AID (Anti-Itch Treatment) Market (Recent past Data for 2005): Percentage Market Share by Volume Sales for Benadryl, Cortizone 10, Cortaid, Aveeno, Cortizone 10 plus, Gold Bond, Lanacane, Lotrimin AF, Lamisil AT, Zanfel, Private Label and Others (includes corresponding Graph/Chart) III-1
    • Table 22: Leading Brands in US Sunscreen/Insect Repellant Market (Recent past Data for 2005): Percentage Market Share by Value Sales for Coppertone Bug & Sun, off Skintastic, Sun & Bug Stuff and Others (includes corresponding Graph/Chart) III-1
    • Table 23: US Recent past, Current & Future Analysis for Medicated Skin Care Products -AnnualSales Figures in US$ Million forYears 2001 through 2010 (includes corresponding Graph/Chart) III-2
    • Table 24: US Long-term Projections for Medicated Skin Care Products - Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-2
    • Table 25: US Historic Review for Medicated Skin Care Products- AnnualSales Figures in US$ Million forYears 1991 through 2000 (includes corresponding Graph/Chart) III-2
    • Table 26: Canadian Recent past, Current & Future Analysis for Medicated Skin Care Products -Annual Sales Figures in US$ Million forYears 2001 through 2010 (includes corresponding Graph/Chart) III-2
    • Table 27: Canadian Long-term Projections for Medicated Skin Care Products -Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-2
    • Table 28: Canadian Historic Review for Medicated Skin Care Products- AnnualSales Figures in US$ Million forYears 1991 through 2000 (includes corresponding Graph/Chart) III-2
    • Table 29: Japanese Recent past, Current & Future Analysis for Medicated Skin Care Products -Annual Sales Figures in US$ Million forYears 2001 through 2010 (includes corresponding Graph/Chart) III-3
    • Table 30: Japanese Long-term Projections for Medicated Skin Care Products - Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-3
    • Table 31: Japanese Historic Review for Medicated Skin Care Products- AnnualSales Figures in US$ Million forYears 1991 through 2000 (includes corresponding Graph/Chart) III-3
    • Table 32: European Recent past, Current & Future Analysis for Medicated Skin Care Products by Geographic Region - France, Germany, Italy, UK, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart) III-3
    • Table 33: European Long-term Projections for Medicated Skin Care Products by Geographic Region - France, Germany, Italy, UK, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-3
    • Table 34: European Historic Review for Medicated Skin Care Products by Geographic Region - France, Germany, Italy, UK, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart) III-3
    • Table 35: European 20-Year Perspective for Medicated Skin Care Products by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, and Rest of Europe Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart) III-3
    • Table 36: French Recent past, Current & Future Analysis for Medicated Skin Care Products -Annual Sales Figures in US$ Million forYears 2001 through 2010 (includes corresponding Graph/Chart) III-3
    • Table 37: French Long-term Projections for Medicated Skin Care Products - Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-3
    • Table 38: French Historic Review for Medicated Skin Care Products- AnnualSales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart) III-3
    • Table 39: German Recent past, Current & Future Analysis for Medicated Skin Care Products -Annual Sales Figures in US$ Million forYears 2001 through 2010 (includes corresponding Graph/Chart) III-4
    • Table 40: German Long-term Projections for Medicated Skin Care Products - Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-4
    • Table 41: German Historic Review for Medicated Skin Care Products- AnnualSales Figures in US$ Million forYears 1991 through 2000 (includes corresponding Graph/Chart) III-4
    • Table 42: Italian Recent past, Current & Future Analysis for Medicated Skin Care Products -Annual Sales Figures in US$ Million forYears 2001 through 2010 (includes corresponding Graph/Chart) III-4
    • Table 43: Italian Long-term Projections for Medicated Skin Care Products - Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-4
    • Table 44: Italian Historic Review for Medicated Skin Care Products- AnnualSales Figures in US$ Million forYears 1991 through 2000 (includes corresponding Graph/Chart) III-4
    • Table 45: Leading Categories in the UK Medicated Skin Care Market (2006): Percentage Breakdown by Value Sales for Washes, Cleansers, Wipes, Treatment creams and gels, Moisturizers, Strips, and Others (includes corresponding Graph/Chart) III-4
    • Table 46: Leading Categories in the UK Medicated Skin Care Market (2006): Percentage Breakdown by Volume Sales for Washes, Cleansers, Wipes, Treatment creams and gels, Moisturizers, Strips, and Others (includes corresponding Graph/Chart) III-4
    • Table 47: UK Recent past, Current & Future Analysis for Medicated Skin Care Products -AnnualSales Figures in US$ Million forYears 2001 through 2010 (includes corresponding Graph/Chart) III-4
    • Table 48: UK Long-term Projections for Medicated Skin Care Products - Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-4
    • Table 49: UK Historic Review for Medicated Skin Care Products- AnnualSales Figures in US$ Million forYears 1991 through 2000 (includes corresponding Graph/Chart) III-4
    • Table 50: Rest of Europe Recent past, Current & Future Analysis for Medicated Skin Care Products-Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart) III-5
    • Table 51: Rest of Europe Long-term Projections for Medicated Skin Care Products-Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-5
    • Table 52: Rest of Europe Historic Review for Medicated Skin Care Products-Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart) III-5
    • Table 53: Leading Players in the Skin Care Market in China (Recent past Data for 2005): Percentage Market Share by Skin Care Brand Sales for Proctor & Gamble (P&G), L'Oreal and Others (includes corresponding Graph/Chart) III-5
    • Table 54: Asia-Pacific Recent past, Current & Future Analysis for Medicated Skin Care Products-Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart) III-5
    • Table 55: Asia-Pacific Long-term Projections for Medicated Skin Care Products - Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-5
    • Table 56: Asia-Pacific Historic Review for Medicated Skin Care Products-Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart) III-5
    • Table 57: Latin American Recent past, Current & Future Analysis for Medicated Skin Care Products- Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart) III-6
    • Table 58: Latin American Long-term Projections for Medicated Skin Care Products - Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-6
    • Table 59: Latin American Historic Review for Medicated Skin Care Products-Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart) III-6

Click here to download the TOC

Delivery Details

PDF:Delivered by email usually within 24 to 48 UK business hours.

Industry Events

Oncology Market & Patient Access

14 Dec 09 to 16 Dec 09
Prague, Czech Republic
view summary >>